Table 5 Detection of anticipated aberrations across platforms for the 6 tumour samples
From: The pitfalls of platform comparison: DNA copy number array technologies assessed
| Â | T1975 | T2701 | T2704 | T2706 | T2707 | T2714 |
|---|---|---|---|---|---|---|
Gain 8p | possibly 8q (all) | also 8q (all) | none | none | none | none, but gain on 8q (all but Nimb) |
Gain 1q | all | all | Â | all | none | all but Nimb |
Loss 16q | partial (all) | and gain 16p (all) | none | and gain 16p (all) | none | none |
Amp 8q24 | all | all | none | none | none | all but Nimb |
Amp 11q13 | none | all | none | none | none | none |
Amp 17q12 | none | none | none | none | none | all |
Amp 20q13 | all | Affy and Agil | none | none | none | none |
Del 13q14 | all | all | none | none | none | none |
Del 9p21 | all but Nimb | all | none | none | none | none |
Del 17p13 | none | all | all | none | none | all |